Investor Relations LatestPress Releases Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates Sep 25, 2023 Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility Sep 25, 2023 Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review btn News IR View All RecentEvents Sep 26, 2023 26 Sep 2023 at 8:30 AM EDT Third-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast Jul 12, 2023 12 Jul 2023 at 8:30 AM EDT Second-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast Jun 13, 2023 13 Jun 2023 at 10:00 AM EDT Oncology Investigator Call for Investors & Analysts: Phase 1 Trial Update Listen to Webcast btn Events View All Financial InformationLatest Earnings Show all Q3 2023 Financial Statement 1 MB MD&A 545.3 KB btn QRs View More PresentationsInvestor Presentation Download PDF
Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
Sep 25, 2023 Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
Sep 26, 2023 26 Sep 2023 at 8:30 AM EDT Third-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast
Jul 12, 2023 12 Jul 2023 at 8:30 AM EDT Second-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast
Jun 13, 2023 13 Jun 2023 at 10:00 AM EDT Oncology Investigator Call for Investors & Analysts: Phase 1 Trial Update Listen to Webcast